Click for best price
Postpemic Era Biosimilar Testing Development Services Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
(Post-pandemic Era)-Global Biosimilar Testing and Development Services Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Biosimilar Testing and Development Services industry at home and abroad, estimate the overall market scale of the Biosimilar Testing and Development Services industry and the market share of major countries, Biosimilar Testing and Development Services industry, and study and judge the downstream market demand of Biosimilar Testing and Development Services through systematic research, Analyze the competition pattern of Biosimilar Testing and Development Services, so as to help solve the pain points of various stakeholders in Biosimilar Testing and Development Services industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Biosimilar Testing and Development Services Market by Research Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Biosimilar Testing and Development Services Market?
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
Major Type of Biosimilar Testing and Development Services Covered in Research report:
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
Application Segments Covered in Research Market
PK assay
Tiered Immunogenicity testing
NAb assays
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Biosimilar Testing and Development Services Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
88 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Biosimilar Testing and Development Services Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Biosimilar Testing and Development Services Market by Value
2.2.1 Global Biosimilar Testing and Development Services Revenue by Type
2.2.2 Global Biosimilar Testing and Development Services Market by Value
2.3 Global Biosimilar Testing and Development Services Market by Sales
2.3.1 Global Biosimilar Testing and Development Services Sales by Type
2.3.2 Global Biosimilar Testing and Development Services Market by Sales
3. The Major Driver of Biosimilar Testing and Development Services Industry
3.1 Historical & Forecast Global Biosimilar Testing and Development Services Sales and Revenue (2018-2028)
3.2 Largest Application for Biosimilar Testing and Development Services (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Biosimilar Testing and Development Services Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Biosimilar Testing and Development Services Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Biosimilar Testing and Development Services Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Biosimilar Testing and Development Services Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Biosimilar Testing and Development Services Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Biosimilar Testing and Development Services Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Biosimilar Testing and Development Services Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Biosimilar Testing and Development Services Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Biosimilar Testing and Development Services Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Biosimilar Testing and Development Services Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Biosimilar Testing and Development Services Average Price Trend
13.1 Market Price for Each Type of Biosimilar Testing and Development Services in US (2018-2022)
13.2 Market Price for Each Type of Biosimilar Testing and Development Services in Europe (2018-2022)
13.3 Market Price for Each Type of Biosimilar Testing and Development Services in China (2018-2022)
13.4 Market Price for Each Type of Biosimilar Testing and Development Services in Japan (2018-2022)
13.5 Market Price for Each Type of Biosimilar Testing and Development Services in India (2018-2022)
13.6 Market Price for Each Type of Biosimilar Testing and Development Services in Korea (2018-2022)
13.7 Market Price for Each Type of Biosimilar Testing and Development Services in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Biosimilar Testing and Development Services in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Biosimilar Testing and Development Services Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Biosimilar Testing and Development Services
15. Biosimilar Testing and Development Services Competitive Landscape
15.1 Eurofins Scientific
15.1.1 Eurofins Scientific Company Profiles
15.1.2 Eurofins Scientific Product Introduction
15.1.3 Eurofins Scientific Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 SGS
15.2.1 SGS Company Profiles
15.2.2 SGS Product Introduction
15.2.3 SGS Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Charles River Laboratories
15.3.1 Charles River Laboratories Company Profiles
15.3.2 Charles River Laboratories Product Introduction
15.3.3 Charles River Laboratories Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Pharmaceutical Product Development
15.4.1 Pharmaceutical Product Development Company Profiles
15.4.2 Pharmaceutical Product Development Product Introduction
15.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Exova
15.5.1 Exova Company Profiles
15.5.2 Exova Product Introduction
15.5.3 Exova Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Source BioScience
15.6.1 Source BioScience Company Profiles
15.6.2 Source BioScience Product Introduction
15.6.3 Source BioScience Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Intertek Group
15.7.1 Intertek Group Company Profiles
15.7.2 Intertek Group Product Introduction
15.7.3 Intertek Group Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Medistri
15.8.1 Medistri Company Profiles
15.8.2 Medistri Product Introduction
15.8.3 Medistri Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Pace Analytical Services
15.9.1 Pace Analytical Services Company Profiles
15.9.2 Pace Analytical Services Product Introduction
15.9.3 Pace Analytical Services Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 Sigma-Aldrich
15.10.1 Sigma-Aldrich Company Profiles
15.10.2 Sigma-Aldrich Product Introduction
15.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Biosimilar Testing and Development Services Industry (Volume)
Figure 2. Biosimilar Testing and Development Services Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Biosimilar Testing and Development Services Revenue in 2022
Figure 5. US Biosimilar Testing and Development Services Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Biosimilar Testing and Development Services Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Biosimilar Testing and Development Services Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Biosimilar Testing and Development Services Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Biosimilar Testing and Development Services Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Biosimilar Testing and Development Services Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Biosimilar Testing and Development Services Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Biosimilar Testing and Development Services Revenue, by Type (Million USD) (2018-2028)
Table 4. Biosimilar Testing and Development Services Sales, by Type (K Unit) (2018-2028)
Table 5. Biosimilar Testing and Development Services Sales (K Unit) by Application (2018-2028)
Table 6. Biosimilar Testing and Development Services Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Biosimilar Testing and Development Services Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Biosimilar Testing and Development Services Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Biosimilar Testing and Development Services Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Biosimilar Testing and Development Services Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Biosimilar Testing and Development Services Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Biosimilar Testing and Development Services Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Biosimilar Testing and Development Services Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Biosimilar Testing and Development Services Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Biosimilar Testing and Development Services in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Biosimilar Testing and Development Services in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Biosimilar Testing and Development Services in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Biosimilar Testing and Development Services in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Biosimilar Testing and Development Services in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Biosimilar Testing and Development Services in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Biosimilar Testing and Development Services in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Eurofins Scientific Profiles
Table 61. Eurofins Scientific Biosimilar Testing and Development Services Product Introduction
Table 62. Eurofins Scientific Biosimilar Testing and Development Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Eurofins Scientific Strategic initiatives
Table 64. SGS Profiles
Table 65. SGS Biosimilar Testing and Development Services Product Introduction
Table 66. SGS Biosimilar Testing and Development Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. SGS Strategic initiatives
Table 68. Charles River Laboratories Profiles
Table 69. Charles River Laboratories Biosimilar Testing and Development Services Product Introduction
Table 70. Charles River Laboratories Biosimilar Testing and Development Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Charles River Laboratories Strategic initiatives
Table 72. Pharmaceutical Product Development Profiles
Table 73. Pharmaceutical Product Development Biosimilar Testing and Development Services Product Introduction
Table 74. Pharmaceutical Product Development Biosimilar Testing and Development Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Pharmaceutical Product Development Strategic initiatives
Table 76. Exova Profiles
Table 77. Exova Biosimilar Testing and Development Services Product Introduction
Table 78. Exova Biosimilar Testing and Development Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Exova Strategic initiatives
Table 80. Source BioScience Profiles
Table 81. Source BioScience Biosimilar Testing and Development Services Product Introduction
Table 82. Source BioScience Biosimilar Testing and Development Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Source BioScience Strategic initiatives
Table 84. Intertek Group Profiles
Table 85. Intertek Group Biosimilar Testing and Development Services Product Introduction
Table 86. Intertek Group Biosimilar Testing and Development Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Intertek Group Strategic initiatives
Table 88. Medistri Profiles
Table 89. Medistri Biosimilar Testing and Development Services Product Introduction
Table 90. Medistri Biosimilar Testing and Development Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Medistri Strategic initiatives
Table 92. Pace Analytical Services Profiles
Table 93. Pace Analytical Services Biosimilar Testing and Development Services Product Introduction
Table 94. Pace Analytical Services Biosimilar Testing and Development Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Pace Analytical Services Strategic initiatives
Table 97. Sigma-Aldrich Profiles
Table 98. Sigma-Aldrich Biosimilar Testing and Development Services Product Introduction
Table 99. Sigma-Aldrich Biosimilar Testing and Development Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Sigma-Aldrich Strategic initiatives
